Moflaxa (Moxifloxacin)

Moxifloxacin, the active ingredient in Moflaxa, is a fluoroquinolone presented as an injection for intravenous use. It treats a range of serious bacterial infections in adult patients.

GNH USA supplies Moflaxa as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibacterial indicated for several serious infections.

- Community-acquired pneumonia: effective treatment of bacterial pneumonia in adults. - Acute bacterial sinusitis: resolves sinus infection caused by susceptible organisms. - Skin and soft tissue infections: combats bacterial cellulitis and wound infections. - Intra-abdominal infections: targets mixed aerobic and anaerobic pathogens. - Complicated urinary tract infections: eradicates resistant uropathogens in complicated cases.

Moxifloxacin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of ventricular arrhythmias. - Clostridioides difficile infection: severe colitis after antibiotic exposure. - Severe allergic reactions: anaphylaxis, angioedema. - Hepatic failure: rare but potentially life‑threatening liver injury. - Seizures: particularly in patients with CNS disorders.

Before using Moflaxa, consider the following safety measures.

- Renal impairment: adjust dosing as per prescriber guidance. - History of tendon disorders: avoid use due to increased rupture risk. - QT prolongation risk: monitor ECG and avoid concomitant QT‑prolonging drugs. - Concurrent antacids or supplements containing aluminum or magnesium: separate administration by at least 2 hours. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Moflaxa can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Other fluoroquinolones: increased risk of cumulative toxicity. - QT‑prolonging agents (e.g., macrolides, antiarrhythmics): heightened arrhythmia risk. - Antacids or supplements with aluminum/magnesium: markedly reduces absorption.

Moderate Interactions (Monitor Closely): - NSAIDs: may diminish antibacterial activity. - Corticosteroids: increased risk of tendon rupture. - Theophylline: may raise plasma theophylline concentrations.